causaLens
PrivateLast Round
Series A
Jan 27, 2022
Est. Valuation
$250M
Total Funding Raised
$51.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
causaLens is an artificial intelligence company that provides a causal AI platform designed to help enterprises automate decision-making and optimize business outcomes.
Sector
AI, Data & Cloud Infrastructure
Verticals
ML Platforms, Business Intelligence, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
causaLens Comparables
Compare causaLens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geminos Software | 79% | |
| VELDT Inc. | 77% | |
| DataRobot | 71% | |
causaLens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 27, 2022 | ||||
| Seed | Apr 1, 2019 | ||||
| Seed | Nov 27, 2018 |
Key People
Founding team and executive leadership
causaLens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Generation Ventures | Series A, Seed |
| Dorilton Ventures | Series A |
| LetterOne | Series A |
| Dorilton | Series A |
| IQ Capital | Seed, Series A |
| Dorilton Ventures | Series A |
| Generation Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 45% MoM, reaching 27.2K.
- Mar 1, 2026
IPG Group referenced as a new customer.
causaLens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about causaLens's valuation, stock price, and market status.